Review of cannabis effects on pregnancy, fetus, and newborn finds significant concerns

A review of cannabis use during pregnancy found evidence of effects on newborns and developmental delays in the first two years, while also noting significant gaps in the research.

RTHC-02712ReviewModerate Evidence2020RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Review
Evidence
Moderate Evidence
Sample
Not reported

What This Study Found

The review summarizes evidence that prenatal cannabis exposure is associated with lower birth weight, neonatal effects, and developmental delays during the first two years of life. It also highlights the increasing use of synthetic cannabinoids during pregnancy, which may pose even greater risks due to their higher potency.

Key Numbers

Developmental delay documented in first 2 years of life in exposed infants; synthetic cannabinoids noted as having greater psychotropic activity and harm potential.

How They Did This

Narrative review covering legislation, physiology, pathophysiology of perinatal cannabis use, neonatal effects, breastfeeding considerations, and developmental outcomes in the first two years.

Why This Research Matters

Cannabis use during pregnancy is increasing, often to treat nausea. This review consolidates what is known about risks to help inform clinical guidance in a space with many unanswered questions.

The Bigger Picture

The growing availability of both natural and synthetic cannabis products creates urgent need for better evidence on prenatal exposure. The gap between increasing use and limited research leaves clinicians and patients making decisions with incomplete information.

What This Study Doesn't Tell Us

Narrative review format; many cited studies have confounding factors (tobacco, alcohol, socioeconomic status); limited ability to isolate cannabis effects; most evidence is observational.

Questions This Raises

  • ?Does the route of cannabis administration affect fetal exposure?
  • ?Are synthetic cannabinoids a growing concern in pregnant populations?

Trust & Context

Key Stat:
Developmental delay documented through first 2 years in prenatally exposed infants
Evidence Grade:
Moderate: synthesizes existing evidence including observational studies, but narrative format and many confounders in underlying research.
Study Age:
Published 2020.
Original Title:
Marijuana: the effects on pregnancy, the fetus, and the newborn.
Published In:
Journal of perinatology : official journal of the California Perinatal Association, 40(10), 1470-1476 (2020)
Database ID:
RTHC-02712

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

Summarizes existing research on a topic.

What do these levels mean? →

Frequently Asked Questions

Is cannabis safe during pregnancy?

Based on this review, there is evidence of associations with lower birth weight and developmental delays in the first 2 years. The evidence has significant gaps, but the available data raises concerns.

What about breastfeeding and cannabis?

The review discusses breastfeeding recommendations and notes that THC can be present in breast milk, raising concerns about infant exposure.

Read More on RethinkTHC

Cite This Study

RTHC-02712·https://rethinkthc.com/research/RTHC-02712

APA

Martin, Gilbert I. (2020). Marijuana: the effects on pregnancy, the fetus, and the newborn.. Journal of perinatology : official journal of the California Perinatal Association, 40(10), 1470-1476. https://doi.org/10.1038/s41372-020-0708-z

MLA

Martin, Gilbert I. "Marijuana: the effects on pregnancy, the fetus, and the newborn.." Journal of perinatology : official journal of the California Perinatal Association, 2020. https://doi.org/10.1038/s41372-020-0708-z

RethinkTHC

RethinkTHC Research Database. "Marijuana: the effects on pregnancy, the fetus, and the newb..." RTHC-02712. Retrieved from https://rethinkthc.com/research/martin-2020-marijuana-the-effects-on

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.